Alterola Biotech, Inc. filed its 10-K on Jun 10, 2022 for the period ending Mar 31, 2022. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | +21.21% |
|
0.00% | +455.56% |
1st Jan change | Capi. | |
---|---|---|
+455.56% | 29.35M | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.25% | 26.22B | |
-25.37% | 19.01B | |
-19.88% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- ABTI Stock
- News Alterola Biotech, Inc.
- Alterola Biotech, Inc. Auditor Raises 'Going Concern' Doubt